Treatment Cannula Infusion
Treatment Cannula Infusion - Related Videos
10:19
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
0 Views •
Cited by 11 •
2016
To study the effects of Aβo in vivo, we developed a model based on repeated hippocampal infusions of soluble Aβo coupled with continuous infusion of Aβo antibody (6E10) in the hippocampus using osmotic pumps to counteract the neurotoxic effect of Aβo.
08:18
A Model of Chronic Nutrient Infusion in the Rat
0 Views •
Cited by 1 •
2013
A protocol for chronic infusions of glucose and Intralipid in rats is described. This model can be used to study the impact of nutrient excess on organ function and physiological parameters.
05:22
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
0 Views •
Cited by 7 •
2023
Central nervous system (CNS) tumors are the leading cause of cancer-related death in children, and locoregional immune-based therapies are increasingly being tested for patients in clinical trials. This protocol describes methods for locoregional cannula implantation in mice for the preclinical evaluation of immunotherapeutic infusions targeting CNS tumors.
04:01
Cannula Implantation into the Cisterna Magna in a Mouse Model
0 Views •
2025
Source: Xavier, A. L. R., et al. Cannula Implantation into the Cisterna Magna of Rodents. J. Vis. Exp. (2018)This video demonstrates the procedure for implanting a cannula into the cisterna magna of an anesthetized mouse. The technique involves guiding a needle-mounted cannula through the dura into the inverted triangular cisterna magna and securing it for targeted delivery into the cerebrospinal fluid.
02:16
Microfluidic-Based Microinjectrode System for Combined Drug Infusion and Electrophysiology
0 Views •
2025
Source: Vanegas, M. I., et al. Microinjectrode System for Combined Drug Infusion and Electrophysiology. J. Vis. Exp. (2019)This video demonstrates a microelectrode-based microfluidic device that delivers drug solution through a capillary tube, using an oil-based marker solution for precise volume tracking and enabling simultaneous neural recording and drug infusion.
FAQs
Infusion rate and volume are the main controllable variables for regulating exposure during treatment cannula infusion. Adjusting the rate changes how quickly the therapeutic solution is delivered, while changing volume alters the amount administered. Keeping these variables defined helps maintain consistent dosing conditions and makes treatment responses easier to compare across experimental groups.
The placement site determines whether administration is directed to a defined local location or contributes to a systemic response. This distinction is important when interpreting efficacy, inflammation, pathogen control, or complications, because the observed result may reflect where the treatment was delivered as well as the treatment itself. Placement therefore links delivery strategy to experimental outcome.
Maintaining sterile conditions supports consistent administration while researchers evaluate treatment efficacy, inflammation, pathogen control, and potential complications. A controlled sterile procedure helps keep the experimental focus on the therapeutic solution and its delivery. This is particularly important when comparing responses across animal models or experimental systems that receive different treatments.
A controlled workflow begins by selecting the therapeutic solution and defined delivery location, placing the cannula in a vessel, tissue, or body cavity, and regulating infusion rate and volume. Sterile conditions are maintained throughout administration. Researchers then assess localized or systemic responses, treatment efficacy, inflammation, pathogen control, and potential complications.
Treatment cannula infusion can administer drugs, antibodies, fluids, or other test treatments, depending on the experimental question. In immunology and infection studies, this flexibility allows investigators to examine how different interventions affect inflammation, pathogen control, or broader treatment efficacy. The approach supports evaluation of multiple treatment types under defined delivery conditions.
It can provide information about both treatment performance and biological response. Researchers may examine whether an intervention improves treatment efficacy, changes inflammation, supports pathogen control, or produces potential complications. Because delivery can be directed to a defined location and controlled by rate and volume, findings can be interpreted in relation to localized versus systemic effects.